Correlation Between Lexicon Pharmaceuticals and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lexicon Pharmaceuticals and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lexicon Pharmaceuticals and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lexicon Pharmaceuticals and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Lexicon Pharmaceuticals and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lexicon Pharmaceuticals with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lexicon Pharmaceuticals and Hepion Pharmaceuticals.
Diversification Opportunities for Lexicon Pharmaceuticals and Hepion Pharmaceuticals
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Lexicon and Hepion is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Lexicon Pharmaceuticals and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Lexicon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lexicon Pharmaceuticals are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Lexicon Pharmaceuticals i.e., Lexicon Pharmaceuticals and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lexicon Pharmaceuticals and Hepion Pharmaceuticals
Given the investment horizon of 90 days Lexicon Pharmaceuticals is expected to generate 0.67 times more return on investment than Hepion Pharmaceuticals. However, Lexicon Pharmaceuticals is 1.5 times less risky than Hepion Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 229.00 in Lexicon Pharmaceuticals on November 2, 2024 and sell it today you would lose (152.67) from holding Lexicon Pharmaceuticals or give up 66.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lexicon Pharmaceuticals vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Lexicon Pharmaceuticals |
| Hepion Pharmaceuticals |
Lexicon Pharmaceuticals and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lexicon Pharmaceuticals and Hepion Pharmaceuticals
The main advantage of trading using opposite Lexicon Pharmaceuticals and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lexicon Pharmaceuticals position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Lexicon Pharmaceuticals vs. BioLineRx | Lexicon Pharmaceuticals vs. Ardelyx | Lexicon Pharmaceuticals vs. Seres Therapeutics | Lexicon Pharmaceuticals vs. Immunitybio |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |